Selective Raf inhibition in cancer therapy

Author： Khazak Vladimir   Astsaturov Igor   Serebriiskii Ilya G   Golemis Erica A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.12, 2007-12, pp. : 1587-1609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New RAF kinase inhibitors in cancer therapy

By Martin-Liberal Juan   Larkin James  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II RAF kinase inhibitors in cancer therapy

By Turajlic Samra   Ali Zohra   Yousaf Nadia   Larkin James  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 739-749

Informa Healthcare

Access to resources Recommend Favorite

RET inhibition: implications in cancer therapy

By Borrello Maria Grazia   Ardini Elena   Locati Laura D   Greco Angela   Licitra Lisa   Pierotti Marco A  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 403-419

Informa Healthcare

Access to resources Recommend Favorite

TGF Beta Inhibition for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 565-578

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Approaches for the Selective Killing of Cancer Cells

By  

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1683-1694

Bentham Science Publishers

Access to resources Recommend Favorite